3-(Difluoromethoxy)aniline | CAS:22236-08-4

We serve 3-(Difluoromethoxy)aniline CAS:22236-08-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-(Difluoromethoxy)aniline

Chemical Name:3-(Difluoromethoxy)aniline
CAS.NO:22236-08-4
Synonyms:3-(Difluoromethoxy)aniline
3-difluoromethoxyphenylamine
3-difluoromethoxy aniline
m-difluoromethoxyaniline
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 230.1±30.0 °C at 760 mmHg
Molecular Formula C7H7F2NO
Molecular Weight 159.133
Flash Point 92.9±24.6 °C
Vapour Pressure 0.1±0.5 mmHg at 25°C
Index of Refraction 1.502
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 3-(Difluoromethoxy)aniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,m-difluoromethoxyaniline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-difluoromethoxyphenylamine Use and application,3-difluoromethoxy aniline technical grade,usp/ep/jp grade.


Related News: Advanced intermediate suppliers not only have strong bargaining power for junior suppliers, but more importantly, because they undertake the production of advanced intermediates with high technical content and maintain closer ties with multinational companies, raw materials Price fluctuations have little effect on it.2-Bromo-5-fluoropyridine manufacturer DPH and BPHC continue to work closely with the CDC to maintain vigilance during this virus outbreak.2'-Deoxy-2'-fluorouridine supplier Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.5-(4-Fluorophenyl)-5-oxopentanoic acid vendor Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.